Biote Corp (BTMD) - Market Cap to Earnings

The price action of biote Corp. (BTMD) demonstrates the -14.50 indicator. The firm's financial stability is bolstered by excess capital generated from high profits from hormone procedures and partnership payments. The team is expanding its B2B segment, attracting experts through a medical training system and generous incentives. Revenue is based on the sale of bioidentical pellets and the training of specialists to assist individuals seeking longevity.

Biote Corporation - BTMD Price to Earnings Ratio (period 04/28/2023 - 11/13/2026)

Comprehensive metric breakdowns and analytics for Biote Corp (BTMD)

- stock value and consensus price forecast:

Stock Quotes biote.com|BTMD - Analyst Consensus Forecast

- market capitalization indicators:

Market Value biote Corp|BTMD - Total Company Value

- book value of equity indicators:

Equity per Share biote Corp.|BTMD - Company Net Assets|Market Cap to Book Value Multiple biote.com|BTMD - Company Total Assets

- company liabilities and liquidity data:

- financial results and valuation multiples details:

BTMD - Net Income|Expected Net Income biote Corp.|BTMD - P/E Multiple|Projected Price to Earnings Biote|BTMD - Price/Earnings to Growth Ratio|Company Value to EBITDA biote Corp|BTMD - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year biote Corp.|BTMD - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months biote.com|BTMD - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year biote Corp.

- issuer revenue and sales details:

BTMD - Revenue and Sales Volume|Company Projected Revenue biote.com|BTMD - Market Cap to Revenue|Price to Expected Revenue Ratio biote Corp

Comprehensive company analysis:BTMD (biote.com)

From a portfolio management perspective, this ratio determines the cost of one dollar of net profit. The relationship between market capitalization and annual income allows for an assessment of whether an asset is overvalued or undervalued. By analyzing changes in the P/E ratio of a company, an investor can discern market expectations regarding business scaling. For biote Corp. (BTMD), this metric reflects the value of future cash flows from its closed-loop hormone therapy system and the sale of nutraceuticals.

Competing companies